Anti-PLK1 monoclonal antibody

Pre-made anti-PLK1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PLK1/PLK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T40694-Ab-1/ GM-Tg-hg-T40694-Ab-2Anti-Human PLK1 monoclonal antibodyHuman
GM-Tg-rg-T40694-Ab-1/ GM-Tg-rg-T40694-Ab-2Anti-Rat PLK1 monoclonal antibodyRat
GM-Tg-mg-T40694-Ab-1/ GM-Tg-mg-T40694-Ab-2Anti-Mouse PLK1 monoclonal antibodyMouse
GM-Tg-cynog-T40694-Ab-1/ GM-Tg-cynog-T40694-Ab-2Anti-Cynomolgus/ Rhesus macaque PLK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T40694-Ab-1/ GM-Tg-felg-T40694-Ab-2Anti-Feline PLK1 monoclonal antibodyFeline
GM-Tg-cang-T40694-Ab-1/ GM-Tg-cang-T40694-Ab-2Anti-Canine PLK1 monoclonal antibodyCanine
GM-Tg-bovg-T40694-Ab-1/ GM-Tg-bovg-T40694-Ab-2Anti-Bovine PLK1 monoclonal antibodyBovine
GM-Tg-equg-T40694-Ab-1/ GM-Tg-equg-T40694-Ab-2Anti-Equine PLK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T40694-Ab-1/ GM-Tg-hg-T40694-Ab-2; GM-Tg-rg-T40694-Ab-1/ GM-Tg-rg-T40694-Ab-2;
GM-Tg-mg-T40694-Ab-1/ GM-Tg-mg-T40694-Ab-2; GM-Tg-cynog-T40694-Ab-1/ GM-Tg-cynog-T40694-Ab-2;
GM-Tg-felg-T40694-Ab-1/ GM-Tg-felg-T40694-Ab-2; GM-Tg-cang-T40694-Ab-1/ GM-Tg-cang-T40694-Ab-2;
GM-Tg-bovg-T40694-Ab-1/ GM-Tg-bovg-T40694-Ab-2; GM-Tg-equg-T40694-Ab-1/ GM-Tg-equg-T40694-Ab-2
Products NameAnti-PLK1 monoclonal antibody
Formatmab
Target NamePLK1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PLK1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T40694-Ag-1Recombinant multi-species PLK1/ PLK/ STPK13 protein
    ORF Viral VectorvGMAP000536Human PLK1 Adenovirus particle
    ORF Viral VectorpGMAP000536Human PLK1 Adenovirus plasmid


    Target information

    Target IDGM-T40694
    Target NamePLK1
    Gene ID5347,18817,25515,697686,489971,101098508,538238,100068388
    Gene Symbol and SynonymsPLK,PLK1,STPK13
    Uniprot AccessionP53350,Q62673,Q2TA25
    Uniprot Entry NamePLK1_HUMAN,PLK1_RAT,PLK1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000166851
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: PLK1, gene name: PLK1, also named as PLK, STPK13. The Ser/Thr protein kinase encoded by this gene belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and elevated levels are found in many different types of cancer. Depletion of this protein in cancer cells dramatically inhibited cell proliferation and induced apoptosis; hence, it is a target for cancer therapy. [provided by RefSeq, Sep 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.